Dama, Azzubayn A.
HRN: 21-45-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/08/2022
06/15/2022
IVT
17mg
Q24H
Occipital Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes